Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
Background: In patients with chronic hepatitis C who do not have a response to antiviral treatment, the disease may progress to cirrhosis, liver failure, hepato-cellular carcinoma, and death. Whether long-term antiviral therapy can prevent progressive liver disease in such patients remains uncertain...
Main Authors: | Mazhar Haque, Eric M. Yoshida, MD, MHSc, FRCP(C), FACP, FACG |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119318186 |
Similar Items
-
Treatment of HCV infection in patients with cirrhosis
by: Angelo Alves de Mattos, et al.
Published: (2010-01-01) -
Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
by: Woo Sun Rou, et al.
Published: (2015-06-01) -
Reversal of Hypolipidemia in Chronic Hepatitis C Patients After Successful Antiviral Therapy
by: Yuan-Hung Kuo, et al.
Published: (2011-06-01) -
Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
by: Young Kul Jung, et al.
Published: (2013-03-01) -
The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment
by: Dong Hyun Park, et al.
Published: (2012-12-01)